- Asthma Center
- Allergy & Immunology
- Childhood Cancer
- Cystic Fibrosis
- Ear, Nose & Throat (ENT)
- Emergency Medicine
- Infectious Diseases
- Medical Genetics
- Newborn Medicine
- Primary Care
- Transplant Programs
- Childrens Express Care
- International Services
- Health Info Management
- Poison Control Center
- Ronald McDonald House
- Social Work
- Telemedicine Program
- Volunteer Services
- Welcome/Info Center
Patients and Families
Planning a Visit
- Get Directions
- Childrens Locations
- Getting Around
- Guidelines for Visitors
- Contact a Patient
- Contact Children's
- Send an e-Card
- Gift Shop
- Find a Doctor
- Child Health A-Z
- Community Ed.Classes
- Injury Prevention
- International Patients
- Medical Records
- Patient Handbook
- Patient Procedures
- Adolescent Medicine
- Babysitting Class
- Diseases & Conditions
- Drugs and Alcohol
- Injury Prevention
- Schools & Jobs
- Sexual Health
- Teen Health
- For Health Professionals
- Ways to Give
- Children's is in the Top 10 Again
- Children's 'Hard Head Patrol' Hits the Streets to Keep Kids Safe
- Adding Breast Milk Ingredient to Formula Could Prevent Deadly Intestinal Problem in Premature Babies
Peter H. Shaw, MD
Job Title Clinical Director, Oncology
Job Title Head of Children's Adolescent and Young Adult (AYA) Oncology Program
Job Title Associate Professor of Pediatrics, University of Pittsburgh School of Medicine
4401 Penn Avenue, Suite Floor 9Pittsburgh, PA 15224
Education and Training
1994 Albert Einstein College of Medicine, Bronx, N.Y.
1997 Montefiore Medical Center, Bronx, N.Y.
2000 Children's Memorial Hospital, Chicago, Ill.
- American Society of Clinical Oncology
- American Society of Pediatric Hematology/Oncology
- American Society of Hematology
- American Academy of Pediatrics
- American Board of Pediatrics - Hematology/Oncology
- 2005-2007 Oustanding Achievement in Patient Care (Top 25 Physician, Overall Quality of Care) Children's Hospital of Pittsburgh of UPMC
- 2003 Oustanding Achievement in Patient Care (Top 10 Physician, Overall Quality of Care) Children's Hospital of Pittsburgh
- 2003 1st Prize, Hemophilia Research Society Research Competition at International Society of Thrombosis and Hemostasis Annual Meeting, Birmingham, UK
- 2002 American Society of Pediatric Hematology/Oncology Young Investigator's Award
- 2000 Children's Hospital of Pittsburgh Research Advisory Committee Faculty Startup Grant
- 2000 Children's Oncology Group Young Investigator Grant
- Shaw PH, Boyiadzis M, Tawbi H, Welsh A, Kemerer A, Davidson NE, Kim Ritchey A. Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions. Cancer. 2012 Jul 15;118(14):3614-7.
- Sidonio RF Jr, Gunawardena S, Shaw PH, Ragni M. Predictors of von Willebrand disease in children. Pediatr Blood Cancer. 2012 May;58(5):736-40.
- Downs-Canner S, Shaw PH. A comparison of clinical trial enrollment between adolescent and young adult (AYA) oncology patients treated at affiliated adult and pediatric oncology centers. J Pediatr Hematol Oncol. 2009 Dec;31(12):927-9.
- Shaw PH, Reynolds S, Gunawardena S, Krishnamurti L, Ritchey AK. The prevalence of bleeding disorders among healthy pediatric patients with abnormal pre-procedural coagulation studies. J Pediatr Hematol Oncol, 2008:30(2):135-141.
- Shaw PH, Ritchey AK. Different Rates of Clinical Trial Enrollment between Adolescents and Young Adults Aged 15 to 21 Years-Old and Children Under 15 Years-Old with Cancer at a Children’s Hospital. J Pediatr Hematol Oncol, 2007:29(12):811-814.
Adolescent and Young Adult Oncology (AYA) Program
Dr. Shaw has established one of the few Adolescent and Young Adult Oncology (AYA) Oncology Programs in the United States at Children's Hospital of Pittsburgh of UPMC. Through this program he studies barriers to providing the best care to this unique population of cancer patients.
Fertility Preservation in Oncology and Bone Marrow Transplant Patients
Dr. Shaw works closely with the Center for Fertility and Reproductive Endocrinology at Magee Women’s Hospital to study cutting-edge approaches to preserve fertility in patients whose curative therapy will adversely affect their ability to reproduce. He is the principal investigator for an IRB-approved protocol to freeze ovarian tissue and co-investigator for an IRB-approved protocol to freeze testicular tissue prior to chemotherapy and/or radiation for appropriate patients.
IRB-approved Bleeding Registry
Dr. Shaw is also interested in the prevalence of true bleeding disorders among children referred for bleeding. An IRB-approved bleeding registry has been established to study this question.
March 21, 2013
March 21, 2013